A story about comments by FDA Commissioner Robert Califf, M.D., about U.S. healthcare shortcomings during the 2023 Stanford Drug Discovery Symposium notes Brian Druker, M.D., discussed his development of the cancer drug Gleevac at the same symposium.

The Lancet Diabetes & Endocrinology profiles Maria Fleseriu, M.D., as a global expert driving excellence in pituitary care. She says, “I have the chance, both for Cushing’s disease and acromegaly, but also other pituitary disorders, to see patients throughout their lives. It is a wonderful thing and an honor for me to get trusted with their care.”

OHSU is a subscriber of Portland General Electric’s new, 162-megawatt solar project in Gillam County.

Alison Edelman, M.D., M.P.H., provides outside expert commentary on a new study based on a mathematical model and whose authors say suggests hormonal birth control dosage can be reduced: “The researchers aren’t taking into account how synthetic hormones are absorbed, metabolized, and excreted. That’s a big deal for contraceptive development where we do these dose-finding studies to see what’s the balance of the lowest dose you can go that gives you the contraceptive effect you’re looking for while also balancing risk and side effects."

Brian Druker, M.D., receives a Lifetime Achievement Award at the 2023 Stanford Drug Discovery Symposium.

Lisa M. Coussens, M.D., Ph.D., says legislation limiting women’s reproductive rights affects a woman’s ability to make difficult, but critical medical decisions when diagnoses with cancer while pregnant or when undergoing cancer therapy and becoming pregnant.

Sandra Rugonyi, Ph.D., and a University of California Irvine scientist are principal investigators for a congenital heart defect study that brought high school students to Rugonyi’s lab and a UCI lab for hands-on research experiences.

Mark Pennesi, M.D., Ph.D., is a new member of the scientific advisory board for Kiora Pharmaceuticals, which is developing new therapies for retinitis pigmentosa and other inherited retinal diseases.

The Blue Ridge Institute for Medical Research reports that OHSU’s family medicine department is in the top five U.S. family medicine departments that received the most NIH funding in 2022.

Jeffrey Tyner, Ph.D., and other OHSU scientists are advising Portland police on best data practices to help them locate stolen cars.